Previous
Previous

Assessment of the therapeutic potential of TATk-hCDKL5 isoform 1 and 2 produced in recombinant Antarctic Pseudoalteromonas haloplanktis TAC125

Next
Next

Clinical trial for antisense oligonucleotide therapy in a patient with ADLD